language_icon
EN
HI

Advanced Enzyme Technologies Share price

ADVENZYMES

371.75

5.05 (-1.34%)
NSE
BSE
Last updated on 27 May, 2026 | 15:45 IST
Today's High

378.25

Today's Low

364.60

52 Week Low

251.95

52 Week High

419.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Advanced Enzyme Technologies Chart

Advanced Enzyme Technologies Share Key Metrics

Volume
1.78 L
Market Cap
4160.88 CR
LTQ@LTP
14@371.75
ATP
369.45
Var Margin
19.69 %
Circuit Range
301.45-452.15
Delivery %
53.19 %
Value
6.59 CR
ASM/GSM
No
Market Lot
1

Summary

Advanced Enzyme Technologies share price is ₹371.75 as of 27 May, 2026. The stock Advanced Enzyme Technologies intraday movement has stayed between ₹364.60 and ₹378.25, while on a 52-week basis,Advanced Enzyme Technologies price 52 week high is ₹419.00 & its 52 week low is ₹251.95.
In terms of trading activity, Advanced Enzyme Technologies has recorded a volume of 178319 shares, The Advanced Enzyme Technologies has a market cap of ₹111926800 CR. The stock’s Average Traded Price (ATP) stands at ₹369.45, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 14 @ ₹371.75.
Advanced Enzyme Technologies operates within a circuit range of ₹301.45 – ₹452.15, with a Value of ₹6.59 CR. The Delivery Percentage for the day is 53.19%. Additionally, Advanced Enzyme Technologies currently falls under the No framework, and trades with a market lot size of 1.

Advanced Enzyme Technologies Fundamentals

View More
P/E Ratio

24.99

P/B Ratio

2.58

Div. Yield

0.36

Sector P/E

71.09

Sector P/B

3.48

Sec. Div. Yield

0.55

Advanced Enzyme Technologies Resistance and Support

Pivot 378.8

Resistance

First Resistance

382.6

Second Resistance

388.4

Third Resistance

392.2

Support

First Support

373

Second Support

369.2

Third Support

363.4

Advanced Enzyme Technologies Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

42.93%

Mutual Fund

5.57%

Insurance

0%

Foreign Institutional Investors

12.58%

Domestic Institutional Investors

2.6%

Retail

36.32%

Others

0%

Total Promoters
MAR '24
43.49%
JUN '24
43.02%
SEP '24
42.95%
DEC '24
42.93%

Advanced Enzyme Technologies Corporate Actions

DateAgenda
2026-05-09Audited Results & Dividend
2026-01-31Quarterly Results
2025-11-12Quarterly Results
2025-08-02Quarterly Results
2025-05-13Audited Results
2025-02-08Quarterly Results

Advanced Enzyme Technologies News

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Advanced Enzyme Tech released the audio recording of its conference call held on May 12, 2026. The call discussed the audited financial results for the quarter and year ended March 31, 2026, and is available on the company's website.
May 12 2026 15:37:42

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Advanced Enzymes Technologies Ltd. announced its Q4 FY26 consolidated results via a press release, with revenue growing 22% YoY to Rs.203.4 crore and net profit increasing 69% to Rs.45.3 crore. Full year FY26 net profit also rose 30% YoY.
May 09 2026 15:23:08

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Cancellation of Dividend

Advanced Enzymes' Board deferred the interim dividend declaration. The company stated this decision aims to preserve capital to provide flexibility for evaluating strategic avenues and maximizing long-term shareholder value.
May 09 2026 14:03:30

Advanced Enzyme Technologies Ltd - 540025 - Corporate Action-Board approves Dividend

Advanced Enzymes recommended a final dividend of ₹1.35 per equity share for FY26. The board deferred the interim dividend to preserve capital for future strategic flexibility.
May 09 2026 13:55:38

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Advanced Enzyme Technologies will host a conference call on May 12, 2026, at 9:00 AM IST, for analysts and investors. The call will discuss the financial results for the quarter and year ended March 31, 2026.
May 05 2026 17:51:47

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Ltd. Board will meet on May 09, 2026. The agenda includes approving annual and Q4 FY26 financial results, and considering both final FY26 and interim FY27 dividends.
May 02 2026 18:24:40

Advanced Enzyme Technologies Limited

Advanced Enzyme board will convene on May 9, 2026, to approve the audited yearly financial results for the period ended March 2026. The meeting will also consider the recommendation of both final and interim dividends.
May 02 2026 18:18:17
Read More

Advanced Enzyme Technologies Management

NamePosition
Sanjay BasantaniCompany Secretary & Compliance Officer, Head-Legal
Vasant RathiChairman
View More

Advanced Enzyme Technologies FAQs

The Buying Price of Advanced Enzyme Technologies share is 371.75 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Advanced Enzyme Technologies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Advanced Enzyme Technologies, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Advanced Enzyme Technologies shares is 24.99. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Advanced Enzyme Technologies shares is 2.58. Useful to assess the stock's value relative to its book value.

To assess Advanced Enzyme Technologies’s valuation compare Sector P/E, P/B which are 71.09 & 3.48 with sector averages, along with growth rates and financial metrics.

The Market Cap of Advanced Enzyme Technologies is 4160.88 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Advanced Enzyme Technologies share price is 419.00 & 251.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Advanced Enzyme Technologies belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost